Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors

Clinical Chemistry

Volumn 40, Issue 1, 1994, Pages 86-95

  Kema, Ido P ^a   De Vries, Elisabeth G E ^a   Slooff, Maarten J H ^a   Biesma, Bonne ^a   Muskiet, Frits A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; 5 HYDROXYINDOLEACETIC ACID; HISTAMINE; METADRENALIN; N METHYLHISTAMINE; NORMETADRENALIN; SEROTONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOID; CARCINOID SYNDROME; CATECHOLAMINE URINE LEVEL; CLINICAL ARTICLE; FEMALE; HISTAMINE METABOLISM; HUMAN; MALE; MIDGUT; THROMBOCYTE; TISSUE LEVEL; TUMOR LOCALIZATION; URINARY EXCRETION;

EID: 0028008415     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/40.1.86     Document Type: Article

References (56)

1. Moertel CG. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1503-22.
2. Williams ED, Sandier M. The classification of carcinoid tumors. Lancet 1963;i:238-9.
3. Maton PN. The carcinoid syndrome. J Am Med Assoc 1988;260: 1602-5.
4. Ahlman H. Serotonin and the carcinoid syndrome. In: VanHoutte PM, ed. Serotonin and the cardiovascular system. New York: Raven Press, 1985:199-212.
5. Pearse AGE. Common cytochemical and ultrastructural characteristics of cells producing hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin. Proc R Soc Lond (Biol) 1968;170:71-80.
6. Pearse AGE. The APUD concept and hormone production. Clin Endocrinol Metab 1980;9:211-22.
7. Norton JA, Doppman JL, Jensen RT. Cancer of the endocrine system. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, principles and practice of oncology, 3rd ed. Philadelphia: JB Lippincott, 1989:1269-344.
8. Kema IP, de Vries EGE, Schellings AMJ, Postmus PE, Muskiet FAJ. Improved diagnosis of carcinoid tumors by measurement of platelet Serotonin. Clin Chem 1992;38:534-40.
9. Campbell ACP, Gowenlock AH, Platt DS, Snow PJD. A 5-hydroxytryptophan-secreting tumor. Gut 1962;3:61-7.
10. Oates JA Sjoerdsma A. A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. Am J Med 1962;32:333-42.
11. Feldman JM. Urinary serotonin in the diagnosis of carcinoid tumors. Clin Chem 1986;32:840-4.
12. Oates JA, Melmon K, Sjoerdsma A, Gillespie L, Mason DT. Release of a kinin peptide in the carcinoid syndrome. Lancet 1964;i:514-7.
13. Norheim I, Oberg K, Theodorsson-Norheim E. Malignant carcinoid tumors. Ann Surg 1987;206:115-25.
14. Feldman JM. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 1986;81:41-8.
15. Sandier M, Karim SMM, Williams ED. Prostaglandins in amine-peptide-secreting tumors. Lancet 1968;ii:1053-5.
16. Feldman JM. Increased dopamine production in patients with carcinoid tumors. Metabolism 1985;34:255-60.
17. Mustala OO, Airaksinen MM. Excretion of histamine and metabolites of 5-hydroxytryptamine in a case of metastasized carcinoid tumor. Acta Med Scand 1962;171:483-9.
18. Snow PDJ. Clinical aspects of carcinoid tumors. In: Varley H, Gowenlock AH, eds. The clinical chemistry of monoamines, Manchester 1962. Amsterdam: Elsevier, 1963:131-4.
19. Gowenlock AH, Platt DS. The clinical chemistry of carcinoid tumors. In: Varley H, Gowenlock AH, eds. The clinical chemistry of monoamines, Manchester 1962. Amsterdam: Elsevier, 1963: 131-4.
20. Nagatsu T. Biochemistry of catecholamines. Tokyo: University Park Press, 1973:50-60.
21. Levine RJ, Sato TL, Sjoerdsma A. Inhibition of histamine synthesis in the rat by α-hydrazino analog of histidine and 4-bromo-3-hydroxybenzyloxamine. Biochem Pharmacol 1965;14: 139-49.
22. Hinterberger H, Tait Smith A, Bartholomew RJ, Sholtz C. Biochemical diagnosis of carcinoid tumors. Pathology 1973;5:1-8.
23. Bader LV, Lykke AWJ, Hinterberger H. Multiple biogenic amine-secreting carcinoid tumor of the stomach: a case report. Pathology 1977;9:353-8.
24. Goedert M, Otten U, Suda K, Heitz PU, Stalder GA, Obrecht JP, et al. Dopamine norepinephrine and serotonin production by an intestinal carcinoid tumor. Cancer 1980;45:104-7.
25. Kwarts E, Kwarts J, Rutgers H. A simple paired-ion liquid chromatography assay for serotonin in cerebrospinal fluid, platelet-rich plasma, serum and urine. Ann Clin Biochem 1984;21: 425-9.
26. Rosano TG, Meola JM, Swift TA Liquid-chromatographic determination of urinary 5-hydroxy-3-indoleacetic acid, with fluorescence detection. Clin Chem 1982;28:207-8.
27. Muskiet FAJ, Statingh MC, Stob GJ, Wolthers BG. Simultaneous determination of the four major catecholamine metabolites and estimation of a serotonin metabolite in urine by capillary gas chromatography of their tert-butyldimethylsilyl derivatives. Clin Chem 1981;27:223-7.
28. Muskiet FAJ, Thomasson CG, Gerding AM, Fremouw-Ottevangers DC, Nagel GT, Wolthers BG. Determination of catecholamines and their 3-O-methylated metabolites in urine by mass fragmentography with use of deuterated internal standards. Clin Chem 1979;25:453-60.
29. Smedes F, Kraak JC, Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr 1982;231:25-39.
30. Kema IP, Schellings AMJ, Meiborg G, Hoppenbrouwers CJM, Muskiet FAJ. Influence of a serotonin- and dopamine-rich diet on platelet serotonin and urinary excretion of biogenic amines and their metabolites. Clin Chem 1992;38:1730-6.
31. Keyzer JJ, Breukelman H, Elzinga H, Koopman BJ, Wolthers BG, Bruins AP. Determination of histamine by chemical ionisation mass spectrometry: application to human urine. Biomed Mass Spectrom 1983;10:480-4.
32. Keyzer JJ, Wolthers BG, Muskiet FAJ, Kauffman HF, Groen A. Determination of N-methylhistamine in plasma and urine by isotope dilution mass fragmentography. Clin Chim Acta 1981;113: 165-73.
33. Conover WJ. Practical nonparametric statistics, 2nd ed. New York: John Wiley, 1980:229-39.
34. Wright PS. Adjusted P-values for simultaneous interference. Biometrics 1992;48:1005-13.
35. Muskiet FAJ, Fremouw-Ottevangers DC, Wolthers BG, de Vries JA. Gas-chromatographic profiling of urinary acidic and alcoholic catecholamine metabolites. Clin Chem 1977;23:863-7.
36. Muskiet FAJ, Groen A. Urinary excretion of conjugated homovanillic acid, 3,4-dihydroxyphenylacetic acid, p-hydroxyphenylacetic acid, and vanillic acid by persons on their usual diet and patients with neuroblastoma. Clin Chem 1979;25:1281-4.
37. Biesma B, Willemse PHB, Mulder NH, Verschueren RCJ, Kema IP, de Bruijn HWA, et al. Recombinant interferon α-2b in patients with metastatic apudomas: effect of tumours and tumour markers. Br J Cancer 1992;66:850-5.
38. Feldman JM, Butler SS, Chapman BA, Bivens CE. Catecholamine metabolism in the carcinoid syndrome. Clin Chim Acta 1974;51:75-81.
39. Fleisher M, Dollinger MR, Schwartz MK. Effect of 5-hydroxyindoleacetic acid in the colorimetric determination of urinary vanilmandelic acid. Am J Clin Pathol 1969;51:555-8.
40. Studnitz WV. On the excretion of 3-methoxy-4-hydroxymandelic acid in patients with serotonin producing tumors. Scand J Clin Lab Invest 1959;11:309-11.
41. Kopin IJ. Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 1985;37:333-64.
42. Graham PE, Smythe GA, Edwards GA, Lazarus L. Laboratory diagnosis of phaeochromocytoma: which analytes should we measure? Ann Clin Biochem 1993;30:129-34.
43. Rosano TG, Swift TA, Hayes LW. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem 1991;37(Suppl):1854-67.
44. Landsberg L, Young JB. Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology. Philadelphia: Saunders, 1985:891-965.
45. Farthing MJG. 5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists. Scand J Gastroenterol 1991;26 S188: 92-100.
46. Stoltz JF. Uptake and storage of serotonin by platelets. In: VanHoutte PM, ed. Serotonin and the cardiovascular system. New York: Raven Press, 1985:199-212.
47. Da Prada M, Picotti GB. Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmacol 1979;65:653-62.
48. Da Prada M, Pletscher A. Storage of exogenous monoamines and reserpine in 5-hydroxytryptamine organelles of blood platelets. Eur J Pharmacol 1969;7:45-8.
49. Feyrter F, Hertting G, Hornykiewicz O. The biological activity of extracts from bronchial carcinoid tumors. Wien Klin Wochenschr 1959;71:317-20.
50. 2 receptor antagoniste. N Engl J Med 1979; 300:236-8.
51. Keyzer JJ, de Monchy JGR, van Doormaal JJ, van Voorst Vader PC. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites. N Engl J Med 1983;309:1603-5.
52. Levine BJ, Sjoerdsma A. Pressor amines and the carcinoid flush. Ann Intern Med 1963;58:818-28.
53. Peart WS, Robertson JIS, Andrews TM. Facial flushing produced in patients with carcinoid syndrome by intravenous adrenaline and noradrenaline. Lancet 1959;ii:715-6.
54. Nilsson O, Gronstad KO, Goldstein M, Skolnik G, Dahlstrom A, Ahlman H. Adrenergic control of serotonin release from a midgut carcinoid tumor. Int J Cancer 1985;36:307-12.
55. Gronstad KO, Nilsson O, Hedman I, Skolnik G, Dahlstrom A, Ahlman H. On the mode of action of the pentagastrin test in the carcinoid syndrome. Scand J Gastroenterol 1985;20:508-11.
56. Gronstad KO, Ahlund L, Dahlstrom A, Haggendal J, Ahlman H. A possible mechanism for the release of serotonin from the gut caused by pentagastrin. J Surg Res 1988;44:473-8.